158 related articles for article (PubMed ID: 38069633)
1. Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening.
Tian Z; Octaviani S; Huang J
Expert Opin Ther Targets; 2023; 27(12):1173-1176. PubMed ID: 38069633
[No Abstract] [Full Text] [Related]
2. [Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].
Yamauchi T
Rinsho Ketsueki; 2019; 60(7):810-817. PubMed ID: 31391371
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
[TBL] [Abstract][Full Text] [Related]
4. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
[TBL] [Abstract][Full Text] [Related]
5. Refining CRISPR-based genome and epigenome editing off-targets.
Luo Y
Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
[No Abstract] [Full Text] [Related]
6. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
Moses C; Kaur P
Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
[TBL] [Abstract][Full Text] [Related]
7. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-P 2.0: An Improved CRISPR-Cas9 Tool for Genome Editing in Plants.
Liu H; Ding Y; Zhou Y; Jin W; Xie K; Chen LL
Mol Plant; 2017 Mar; 10(3):530-532. PubMed ID: 28089950
[No Abstract] [Full Text] [Related]
9. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
10. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
Maier LK; Marchfelder A; Randau L
Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
[No Abstract] [Full Text] [Related]
11. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
Ahmed MZ; Badani P; Reddy R; Mishra G
J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
[TBL] [Abstract][Full Text] [Related]
12. Systems Analysis of Highly Multiplexed CRISPR-Base Editing in Streptomycetes.
Whitford CM; Gren T; Palazzotto E; Lee SY; Tong Y; Weber T
ACS Synth Biol; 2023 Aug; 12(8):2353-2366. PubMed ID: 37402223
[TBL] [Abstract][Full Text] [Related]
13. Modeling pediatric AML FLT3 mutations using CRISPR/Cas12a- mediated gene editing.
Rivera-Torres N; Banas K; Kmiec EB
Leuk Lymphoma; 2020 Dec; 61(13):3078-3088. PubMed ID: 32815753
[TBL] [Abstract][Full Text] [Related]
14. Treating Genetic Disorders Using State-Of-The-Art Technology.
Jamal M; Ullah A; Ahsan M; Tyagi R; Habib Z; Khan FA; Rehman K
Curr Issues Mol Biol; 2018; 26():33-46. PubMed ID: 28879854
[TBL] [Abstract][Full Text] [Related]
15. Keeping our eyes on CRISPR: the "Atlas" of gene editing.
Wang W; Hou J; Zheng N; Wang X; Zhang J
Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372
[No Abstract] [Full Text] [Related]
16. Efficient multiplex genome editing by CRISPR/Cas9 in common wheat.
Li J; Zhang S; Zhang R; Gao J; Qi Y; Song G; Li W; Li Y; Li G
Plant Biotechnol J; 2021 Mar; 19(3):427-429. PubMed ID: 33150679
[No Abstract] [Full Text] [Related]
17. [CRISPR/Cas-based genome editing in Aspergillus niger].
Zheng X; Zheng P; Sun J
Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
19. Recent advances in the CRISPR genome editing tool set.
Moon SB; Kim DY; Ko JH; Kim YS
Exp Mol Med; 2019 Nov; 51(11):1-11. PubMed ID: 31685795
[TBL] [Abstract][Full Text] [Related]
20. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
